Roshani, S.; van Leeuwen, F.E.; Rossetti, S.; Hauptmann, M.; Visser, O.; Zijlstra, J.M.; Hutchings, M.; Schaapveld, M.; Aleman, B.M.P.
Predicting Absolute Risk of First Relapse in Classical Hodgkin Lymphoma by Incorporating Contemporary Treatment Effects. Cancers 2025, 17, 2760.
https://doi.org/10.3390/cancers17172760
AMA Style
Roshani S, van Leeuwen FE, Rossetti S, Hauptmann M, Visser O, Zijlstra JM, Hutchings M, Schaapveld M, Aleman BMP.
Predicting Absolute Risk of First Relapse in Classical Hodgkin Lymphoma by Incorporating Contemporary Treatment Effects. Cancers. 2025; 17(17):2760.
https://doi.org/10.3390/cancers17172760
Chicago/Turabian Style
Roshani, Shahin, Flora E. van Leeuwen, Sara Rossetti, Michael Hauptmann, Otto Visser, Josée M. Zijlstra, Martin Hutchings, Michael Schaapveld, and Berthe M. P. Aleman.
2025. "Predicting Absolute Risk of First Relapse in Classical Hodgkin Lymphoma by Incorporating Contemporary Treatment Effects" Cancers 17, no. 17: 2760.
https://doi.org/10.3390/cancers17172760
APA Style
Roshani, S., van Leeuwen, F. E., Rossetti, S., Hauptmann, M., Visser, O., Zijlstra, J. M., Hutchings, M., Schaapveld, M., & Aleman, B. M. P.
(2025). Predicting Absolute Risk of First Relapse in Classical Hodgkin Lymphoma by Incorporating Contemporary Treatment Effects. Cancers, 17(17), 2760.
https://doi.org/10.3390/cancers17172760